Home > Products > CD28 & CSPG4 > Recombinant Anti-CD28 x Anti-CSPG4 Bispecific Antibody (Tandem Diabody)

Recombinant Anti-CD28 x Anti-CSPG4 Bispecific Antibody (Tandem Diabody)  (CAT#: T-BSDB-063)

Recombinant Anti-CD28 x Anti-CSPG4 Bispecific Antibody (Tandem Diabody) is designed to be expressed as a monomeric subunit (single chain Diabody, scDb), with four variable domains from two parental antibodies. Then the two peptide chains can dimerize in a head-to-tail fashion. This BsAb can retarget T cells to tumor cells. It is designed for the research of Melanoma therapy.
Datasheet INQUIRY

Specifications

Targets
CD28 & CSPG4
Species Reactivity
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Melanoma

Targets

Target 1
CD28
Gene ID
UniProt ID
Alternative Names
CD28; CD28 molecule; Cluster of Differentiation 28; Tp44; T-cell-specific surface glycoprotein CD28; CD28 antigen
Target 2
CSPG4
Gene ID
UniProt ID
Alternative Names
NG2; Neuron-glial antigen 2; Melanoma-associated chondroitin sulfate proteoglycan; chondroitin sulfate proteoglycan 4; CSPG4; MCSP; MCSPG; MSK16; HMW-MAA; MEL-CSPG
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

Related products of "CD28 & CSPG4"
See other bsAb targets related to "CD28"

See other bsAb targets related to "CSPG4"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD28 x Anti-CSPG4 Bispecific Antibody (Tandem Diabody) (T-BSDB-063). Click the button below to contact us or submit your feedback about this product.